Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Healthtrust
McKinsey
Mallinckrodt
Colorcon
Queensland Health
Teva
Argus Health

Generated: May 26, 2018

DrugPatentWatch Database Preview

DURANEST Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Duranest patents expire, and when can generic versions of Duranest launch?

Duranest is a drug marketed by Astrazeneca and Dentsply Pharm and is included in two NDAs.

The generic ingredient in DURANEST is etidocaine hydrochloride. Additional details are available on the etidocaine hydrochloride profile page.
Drug patent expirations by year for DURANEST
Medical Subject Heading (MeSH) Categories for DURANEST
Synonyms for DURANEST
(.+/-.)-2-(Ethylpropylamino)-2',6'-butyroxylidide
(+-)-2-(Ethylpropylamino)-2',6'-butyroxylidide
(+-)-N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butanamide
2-(Ethylpropylamino)-2',6'-butyroxylidide
2',6'-BUTYROXYLIDIDE, 2-(ETHYLPROPYLAMINO)-
36637-18-0
38188-41-9
38188-42-0
60108-68-1
AC1L1XUQ
AC1Q5LWD
AN-5631
BC686212
BRN 2741181
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (-)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (.+/-.)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+-)-
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (+)-
C07530
CAS-36637-18-0
CHEBI:4904
CHEMBL492
D04095
D0G7DJ
DB08987
DSSTox_CID_3027
DSSTox_GSID_23027
DSSTox_RID_76836
DTXSID1023027
EINECS 253-143-8
Etidocaina
Etidocaina [INN-Spanish]
Etidocaine
Etidocaine (USAN/INN)
Etidocaine [USAN:BAN:INN]
Etidocaine [USAN:INN:BAN]
Etidocaine HCl
Etidocaine hydrochloride
Etidocaine, (-)-
Etidocaine, (+)-
Etidocainum
Etidocainum [INN-Latin]
FT-0700005
GTPL2621
K9D2CE52PU
LP047928
LS-45490
LS-48493
N-(2,6-dimethylphenyl)-2-(ethyl-propylamino)butanamide
N-(2,6-Dimethylphenyl)-2-(ethylpropylamino)butanamide
N-(2,6-Dimethylphenyl)-2-(N-ethyl-N-propylamino)butyramide
N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide
NCGC00183654-01
OR063134
OR263344
SCHEMBL57261
Tox21_112968
UNII-K9D2CE52PU
UNII-Y83XVY9AQ8
VTUSIVBDOCDNHS-UHFFFAOYSA-N
W-19053
W-19053 [AS HYDROCHLORIDE]
Y83XVY9AQ8

US Patents and Regulatory Information for DURANEST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca DURANEST epinephrine; etidocaine hydrochloride INJECTABLE;INJECTION 017751-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST epinephrine bitartrate; etidocaine hydrochloride INJECTABLE;INJECTION 017751-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST epinephrine bitartrate; etidocaine hydrochloride INJECTABLE;INJECTION 017751-007 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for DURANEST

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca DURANEST etidocaine hydrochloride INJECTABLE;INJECTION 017751-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST epinephrine bitartrate; etidocaine hydrochloride INJECTABLE;INJECTION 017751-006 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST epinephrine; etidocaine hydrochloride INJECTABLE;INJECTION 017751-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Astrazeneca DURANEST epinephrine bitartrate; etidocaine hydrochloride INJECTABLE;INJECTION 017751-007 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cipla
Covington
Express Scripts
UBS
Cerilliant
Merck
Chubb
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.